The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Aurora Kinase Inhibitors: Current Status and Outlook
Open accessAbstract
The Aurora kinase family comprises of cell cycle-regulated serine/threonine kinases important for mitosis. Their activity and protein expression are cell cycle regulated, peaking during mitosis to orchestrate important mitotic processes including centrosome maturation, chromosome alignment, chromosome segregation, and cytokinesis. In humans, the Aurora kinase family consists of three members; Aurora-A, Aurora-B, and Aurora-C, which each share a conserved C-terminal catalytic domain but differ in their sub-cellular localization, substrate specificity, and function during mitosis. In addition, Aurora-A and Aurora-B have been found to be overexpressed in a wide variety of human tumors. These observations led to a number of programs among academic and pharmaceutical organizations to discovering small molecule Aurora kinase inhibitors as anti-cancer drugs. This review will summarize the known Aurora kinase inhibitors currently in the clinic, and discuss the current and future directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216
The cellular geography of Aurora kinases
Carmena, M., & Earnshaw, W. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1245 · Cited by 1,139
The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
Carmena, M., Wheelock, M., Funabiki, H., & Earnshaw, W. C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3474 · Cited by 905
Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
Macůrek, L., Lindqvist, A., Lim, D., Lampson, M. A., Klompmaker, R., Freire, R., Clouin, C., Taylor, S. S., Yaffe, M. B., & Medema, R. H. (2008) · Nature · doi:10.1038/nature07185 · Cited by 710
Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
Seki, A., Coppinger, J. A., Jang, C.-Y., Yates, J. R., & Fang, G. (2008) · Science · doi:10.1126/science.1157425 · Cited by 619
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Otto, T., Horn, S., Brockmann, M., Eilers, U., Schüttrumpf, L., Popov, N., Kenney, A. M., Schulte, J. H., Beijersbergen, R., Christiansen, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.005 · Cited by 573
Sampath, S. C., Ohi, R., Leismann, O., Salic, A., Pozniakovski, A., & Funabiki, H. (2004) · Cell · doi:10.1016/j.cell.2004.06.026 · Cited by 422
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Manfredi, M. G., Ecsedy, J. A., Meetze, K. A., Balani, S. K., Burenkova, O., Chen, W., Galvin, K. M., Hoar, K. M., Huck, J. J., LeRoy, P. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608798104 · Cited by 413
AIM-1: a mammalian midbody-associated protein required for cytokinesis
Terada, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.667 · Cited by 393
Aurora Kinases as Anticancer Drug Targets
Gautschi, O., Heighway, J., Mack, P. C., Purnell, P. R., Lara, P. N., & Gandara, D. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2179 · Cited by 386
Howard, S., Berdini, V., Boulstridge, J. A., Carr, M. G., Cross, D. M., Curry, J., Devine, L. A., Early, T. R., Fazal, L., Gill, A. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800984v · Cited by 333
Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases
Giet, R., & Prigent, C. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.21.3591 · Cited by 314
Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer.
Gritsko, T. M., Coppola, D., Paciga, J. E., Yang, L., Sun, M., Shelley, S. A., Fiorica, J. V., Nicosia, S. V., & Cheng, J. Q. (2003) · PubMed · Cited by 303
Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.
Tanaka, T., Kimura, M., Matsunaga, K., Fukada, D., Mori, H., & Okano, Y. (1999) · PubMed · Cited by 301
Manfredi, M. G., Ecsedy, J. A., Chakravarty, A., Silverman, L., Zhang, M., Hoar, K. M., Stroud, S. G., Chen, W., Shinde, V., Huck, J. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1536 · Cited by 300
The chromosomal passenger complex: guiding Aurora-B through mitosis
Vader, G., Medema, R. H., & Lens, S. M. A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604032 · Cited by 299
Yang, J., Ikezoe, T., Nishioka, C., Tasaka, T., Taniguchi, A., Kuwayama, Y., Komatsu, N., Bandobashi, K., Togitani, K., Koeffler, H. P., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073700 · Cited by 282
Validating Aurora B as an anti-cancer drug target
Girdler, F., Gascoigne, K. E., Eyers, P. A., Hartmuth, S., Crafter, C., Foote, K. M., Keen, N. J., & Taylor, S. S. (2006) · Journal of Cell Science · doi:10.1242/jcs.03145 · Cited by 282
Drugging MYCN through an Allosteric Transition in Aurora Kinase A
Gustafson, W. C., Meyerowitz, J. G., Nekritz, E. A., Chen, J., Benes, C., Charron, E., Simonds, E. F., Seeger, R., Matthay, K. K., Hertz, N. T., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.015 · Cited by 278
Mortlock, A. A., Foote, K. M., Heron, N. M., Jung, F. H., Pasquet, G., Lohmann, J.-J. M., Warin, N., Renaud, F., Savi, C. D., Roberts, N. J., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061335f · Cited by 270
Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
Giet, R., Petretti, C., & Prigent, C. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.004 · Cited by 262
Kimura, M., Matsuda, Y., Yoshioka, T., & Okano, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7334 · Cited by 246
Carpinelli, P., Ceruti, R., Giorgini, M. L., Cappella, P., Gianellini, L., Croci, V., Degrassi, A., Texido, G., Rocchetti, M., Vianello, P., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0444 · Cited by 245
Friedberg, J. W., Mahadevan, D., Cebula, E., Persky, D., Lossos, I., Agarwal, A. B., Jung, J., Burack, R., Zhou, X., Leonard, E. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8793 · Cited by 212
Chesler, L., Schlieve, C., Goldenberg, D. D., Kenney, A., Kim, G., McMillan, A., Matthay, K. K., Rowitch, D., & Weiss, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2769 · Cited by 202
Fancelli, D., Moll, J., Varasi, M., Bravo, R., Artico, R., Berta, D., Bindi, S., Cameron, A., Candiani, I., Cappella, P., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060897w · Cited by 188
Dees, E. C., Cohen, R. B., von Mehren, M., Stinchcombe, T. E., Liu, H., Venkatakrishnan, K., Manfredi, M. G., Fingert, H. J., Burris, H. A., & Infante, J. R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0589 · Cited by 159
Cervantes, A. M. R., Élez, E., Roda, D., Ecsedy, J., Macarulla, T. M., Venkatakrishnan, K., Roselló, S., Andreu, J., Jung, J., Sanchis, J. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0571 · Cited by 153
Tanenbaum, M. E., Macurek, L., van der Vaart, B., Galli, M., Akhmanova, A., & Medema, R. H. (2011) · Current Biology · doi:10.1016/j.cub.2011.07.017 · Cited by 148
Yang, K., Li, S.-K., Chang, C.-C., Tang, C.-J. C., Lin, Y., Lee, S.-C., & Tang, T. K. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-02-0170 · Cited by 141
Matulonis, U. A., Sharma, S. K., Ghamande, S., Gordon, M. S., Prete, S. A. D., Ray-Coquard, I. L., Kutarska, E., Liu, H., Fingert, H. J., Zhou, X., et al. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.06.040 · Cited by 133
Crystal Structure of the T315I Abl Mutant in Complex with the Aurora Kinases Inhibitor PHA-739358
Modugno, M., Casale, E., Soncini, C., Rosettani, P., Colombo, R., Lupi, R., Rusconi, L., Fancelli, D., Carpinelli, P., Cameron, A. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1825 · Cited by 132
CDC25B Phosphorylation by Aurora A Occurs at the G2/M Transition and is Inhibited by DNA Damage
Cazalès, M., Schmitt, E., Montembault, É., Dozier, C., Prigent, C., & Ducommun, B. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1964 · Cited by 131
Payton, M. N., Bush, T. L., Chung, G., Ziegler, B., Eden, P., McElroy, P. L., Ross, S. L., Cee, V. J., Deak, H. L., Hodous, B. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-3001 · Cited by 128
Moore, A. S., Faisal, A., de Castro, D. G., Bavetsias, V., Sun, C., Atrash, B., Valenti, M. R., Brandon, A. D. H., Avery, S., Mair, D., et al. (2012) · Leukemia · doi:10.1038/leu.2012.52 · Cited by 121
Self-citationLöwenberg, B., Muus, P., Ossenkoppele, G. J., Rousselot, P. H., Cahn, J.-Y. Y., Ifrah, N., Martinelli, G., Amadori, S., Berman, E., Sonneveld, P., et al. (2011) · Blood · doi:10.1182/blood-2011-07-366930 · Cited by 121
Mossé, Y. P., Lipsitz, E. G., Fox, E., Teachey, D. T., Maris, J. M., Weigel, B. J., Adamson, P. C., Ingle, M. A., Ahern, C. H., & Blaney, S. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3251 · Cited by 120
Burkhart, C. A., Cheng, A. J., Madafiglio, J., Kavallaris, M., Mili, M., Marshall, G. M., Weiss, W. A., Khachigian, L. M., Norris, M. D., & Haber, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg045 · Cited by 108
Steeghs, N., Eskens, F. A. L. M., Gelderblom, H. A. J., Verweij, J., Nortier, J. W. R., Ouwerkerk, J., van Noort, C., Mariani, M., Spinelli, R., Carpinelli, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6655 · Cited by 106
Kaestner, P., Stolz, A., & Bastians, H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0323 · Cited by 106
Kantarjian, H. M., Martinelli, G., Jabbour, E. J., Quintás‐Cardama, A., Ando, K., Bay, J., Wei, A. H., Gröpper, S., Papayannidis, C., Owen, K., et al. (2013) · Cancer · doi:10.1002/cncr.28113 · Cited by 105
Carol, H., Boehm, I., Reynolds, C. P., Kang, M. H., Maris, J. M., Morton, C. L., Gorlick, R. G., Kolb, E. A., Keir, S. T., Wu, J., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1618-8 · Cited by 99
Moore, A. S., Blagg, J., Linardopoulos, S., et al. (2010) · Leukemia · doi:10.1038/leu.2010.15 · Cited by 96
Self-citationInhibition of Aurora A in response to DNA damage
Krystyniak, A., Garcı́a-Echeverrı́a, C., Prigent, C., & Ferrari, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209056 · Cited by 96
Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues
Ulisse, S., Delcros, J., Baldini, E., Toller, M., Curcio, F., Giacomelli, L., Prigent, C., Ambesi‐Impiombato, F. S., D’Armiento, M., & Arlot‐Bonnemains, Y. (2006) · International Journal of Cancer · doi:10.1002/ijc.21842 · Cited by 95
High Expression of Aurora-B/Aurora and Ipl1-Like Midbody-Associated Protein (AIM-1) in Astrocytomas
Araki, K., Nozaki, K., Ueba, T., Tatsuka, M., & Hashimoto, N. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000021784.33421.05 · Cited by 95
Faisal, A., Vaughan, L. S., Bavetsias, V., Sun, C., Atrash, B., Avery, S., Jamin, Y., Robinson, S. P., Workman, P., Blagg, J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0333 · Cited by 94
Self-citationCohen, R. B., Jones, S. F., Aggarwal, C., von Mehren, M., Cheng, J., Spigel, D. R., Greco, F. A., Mariani, M., Rocchetti, M., Ceruti, R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1445 · Cited by 93
PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
Jani, J. P., Arcari, J. T., Bernardo, V., Bhattacharya, S. K., Briere, D. M., Cohen, B. D., Coleman, K. G., Christensen, J. G., Emerson, E. O., Jakowski, A. B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0915 · Cited by 92
Aurora B expression in normal testis and seminomas
Chieffi, P., Troncone, G., Caleo, A., Libertini, S., Linardopoulos, S., Tramontano, D., & Portella, G. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810263 · Cited by 91
Self-citationBernard, M., Sanséau, P., Henry, C., Couturier, A., & Prigent, C. (1998) · Genomics · doi:10.1006/geno.1998.5522 · Cited by 90
Walsby, E. J., Walsh, V., Pepper, C. J., Burnett, A. K., & Mills, K. (2008) · Haematologica · doi:10.3324/haematol.12148 · Cited by 88
Kelly, K. R., Shea, T. C., Goy, A. H., Berdeja, J. G., Reeder, C. B., McDonagh, K. T., Zhou, X., Danaee, H., Liu, H., Ecsedy, J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-0050-9 · Cited by 83
Goldberg, S. L., Fenaux, P., Craig, M., Gyan, E., LISTER, J. W., Kassis, J., Pigneux, A., Schiller, G. J., Jung, J., Leonard, E. J., et al. (2014) · Leukemia Research Reports · doi:10.1016/j.lrr.2014.06.003 · Cited by 78
Bavetsias, V., Crumpler, S., Sun, C., Avery, S., Atrash, B., Faisal, A., Moore, A. S., Kosmopoulou, M. N., Brown, N., Sheldrake, P. W., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300952s · Cited by 77
Self-citationMeulenbeld, H. J., Bleuse, J. P., Vinci, E. M., Raymond, É., Vitali, G., Santoro, A., Dogliotti, L., Berardi, R., Cappuzzo, F., Tagawa, S. T., et al. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11404.x · Cited by 75
Overexpression of Active Aurora-C Kinase Results in Cell Transformation and Tumour Formation
Khan, J., Ezan, F., Crémet, J.-Y., Fautrel, A., Gilot, D., Lambert, M., Benaud, C. M., Troadec, M., & Prigent, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026512 · Cited by 75
Oke, A., Pearce, D., Wilkinson, R. W., Crafter, C., Odedra, R., Cavenagh, J. D., Fitzgibbon, J., Lister, A. T., Joel, S., & Bonnet, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3203 · Cited by 72
Dennis, M., Davies, M., Oliver, S. D., D'Souza, R. A., Pike, L., & Stockman, P. K. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1939-2 · Cited by 68
Tanaka, R., Squires, M. S., Kimura, S. H., Yokota, A., Nagao, R., Yamauchi, T., Takeuchi, M., Yao, H., Reule, M., Smyth, T., et al. (2010) · Blood · doi:10.1182/blood-2009-03-211466 · Cited by 68
Sourisseau, T., Maniotis, D., McCarthy, A., Tang, C., Lord, C. J., Ashworth, A., & Linardopoulos, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000068 · Cited by 66
Self-citationAT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B‐cell lymphomas
Qi, W., Liu, X., Cooke, L. S., Persky, D. O., Miller, T. P., Squires, M. S., & Mahadevan, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26324 · Cited by 65
Arkenau, H., Plummer, R., Molife, L. R., Olmos, D., Yap, T. A., Squires, M. S., Lewis, S., Lock, V., Yule, M., Lyons, J. F., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr451 · Cited by 65
Borthakur, G. M., Dombret, H., Schafhausen, P., Brümmendorf, T. H., Boissel, N., Jabbour, E., Mariani, M., Capolongo, L., Carpinelli, P., Davite, C., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.115279 · Cited by 60
Schöffski, P., Besse, B., Gauler, T. C., de Jonge, M. J. A., Scambia, G., Santoro, A., Davite, C., Jannuzzo, M. G., Petroccione, A., & Delord, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu566 · Cited by 60
Kantarjian, H. M., Sekeres, M. A., Ribrag, V., Rousselot, P. H., Garcia‐Manero, G., Jabbour, E. J., Owen, K., Stockman, P. K., & Oliver, S. D. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.03.019 · Cited by 59
Schöffski, P., Jones, S. F., Dumez, H., Infante, J. R., Mieghem, E. V., Fowst, C., Gerletti, P., Xu, H., Jakubczak, J. L., English, P. A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.008 · Cited by 59
Kelly, K. R., Nawrocki, S. T., Espitia, C. M., Zhang, M., Yang, J. J., Padmanabhan, S., Ecsedy, J., Giles, F. J., & Carew, J. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27579 · Cited by 58
Bush, T. L., Payton, M. N., Heller, S., Chung, G., Hanestad, K., Rottman, J. B., Loberg, R. D., Friberg, G. R., Kendall, R. L., Saffran, D. C., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1178 · Cited by 57
Tsuboi, K., Yokozawa, T., Sakura, T., Watanabe, T., Fujisawa, S., Yamauchi, T., Uike, N., Ando, K., Kihara, R., Tobinai, K., et al. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.04.008 · Cited by 56
Aurora kinase inhibitors: identification and preclinical validation of their biomarkers
Carpinelli, P., & Moll, J. K. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.1.69 · Cited by 56
Moreno, L., Marshall, L. V., Pearson, A. D. J., Morland, B. J., Elliott, M., Campbell‐Hewson, Q., Makin, G., Halford, S. E. R., Acton, G. D., Ross, P., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1592 · Cited by 56
The clinical development of FLT3 inhibitors in acute myeloid leukemia
Knapper, S. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.611802 · Cited by 55
Curry, J. E., Angove, H. C., Fazal, L., Lyons, J. F., Reule, M., Thompson, N. T., & Wallis, N. G. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8741 · Cited by 55
Tao, Y., Leteur, C., Caldéraro, J., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.19.9729 · Cited by 55
Foran, J. M., Ravandi, F., Wierda, W. G., Garcia‐Manero, G., Verstovšek, S., Kadia, T. M., Burger, J. A., Yule, M., Langford, G. A., Lyons, J. F., et al. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.11.001 · Cited by 51
Geuns-Meyer, S. D., Cee, V. J., Deak, H. L., Du, B., Hodous, B. L., Nguyen, H. N., Olivieri, P. R., Schenkel, L. B., Vaida, K. R., Andrews, P., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00183 · Cited by 46
Dent, S. F., Gelmon, K. A., Chi, K. N., Jonker, D. J., Wainman, N., Capier, C. A., Chen, E. X., Lyons, J. F., & Seymour, L. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-0018-9 · Cited by 25
Will newer tyrosine kinase inhibitors have an impact in AML?
Levis, M. J. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.09.008 · Cited by 10
Cited by
Trends in kinase drug discovery: targets, indications and inhibitor design
Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00252-y · Cited by 779
Aurora kinases: novel therapy targets in cancers
Tang, A., Gao, K., Chu, L., Zhang, R., Yang, J., & Zheng, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14893 · Cited by 382
Shah, K. N., Bhatt, R., Rotow, J., Rohrberg, J., Olivas, V., Wang, V. E., Hemmati, G., Martins, M. M., Maynard, A., Kuhn, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0264-7 · Cited by 286
Current Diagnosis and Management of Small-Cell Lung Cancer
Wang, S., Zimmermann, S., Parikh, K., Mansfield, A. S., & Adjei, A. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.034 · Cited by 282
Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
Shi, J., & Mitchison, T. J. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0003 · Cited by 79
Metadata
- Authors
- Bavetsias, V., & Linardopoulos, S.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2015-12-21
- Volume
- 5
- Pages
- 278-278
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2222507697
- Cited by
- 277
- References
- 80
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.